TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.

Craig Reynolds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.